Drawing for MOLMERICA

USPTO serial 99466718

MOLMERICA

Reg. 8427837Status 700Registered
Filing date
Oct 28, 2025
Status date
Sep 1, 2026
Registration date
Sep 1, 2026
Examiner
DWYER, JOHN D

Need help with MOLMERICA?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Owner

  • AMERICAN MOLECULES LLC

    SUGAR LAND, TX, US

  • AMERICAN MOLECULES LLC

    SUGAR LAND, TX, US

  • AMERICAN MOLECULES LLC

    SUGAR LAND, TX, US

Goods and services

ClassDescriptionStatusFirst use
001Chemical additives for fracturing fluid for use in oil and gas wells; Chemical additives for oil well drilling fluids; Chemical additives for drilling muds; Chemical fracturing fluids for use in the oil and gas industry; Chemical preparations for scientific purposes, other than for medical or veterinary use; Chemical preparations for scientific purposes; Chemical preparations for use in industry; Chemicals used in oil drilling; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the field of oil exploration and production; Hydraulic fluids for general use; Industrial chemicals; Specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; Mineral acids; Persulfates; Organic acid salts; Antioxidants for use in the manufacture of pharmaceuticalsACTIVEApr 28, 2026
005Mineral nutritional supplements; Mineral salts for medical purposes; Mineral supplements; Vitamin and mineral supplements; Mineral preparations for medical purposes; Vitamin and mineral supplements for mixing with foods and beverages; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Veterinary pharmaceutical preparations for the treatment of infectious diseases, cardiovascular diseases, respiratory diseases, diabetes, cancers, autoimmune diseases, tendon and muscle injuries, eye diseases, neurodegenerative diseases; Veterinary pharmaceutical preparations for the prevention of infectious diseases, cardiovascular diseases, respiratory diseases, diabetes, cancers, autoimmune diseases, tendon and muscle injuries, eye diseases, neurodegenerative diseases.ACTIVEMay 23, 2026

Prosecution history

DateCodeEvent
Sep 1, 2026R.PRREGISTERED-PRINCIPAL REGISTER
Aug 13, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 13, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 11, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jun 25, 2026IUAFUSE AMENDMENT FILED
Jun 25, 2026EISUTEAS STATEMENT OF USE RECEIVED
Jun 2, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 7, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026PUBOPUBLISHED FOR OPPOSITION
Apr 1, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2026DOCKASSIGNED TO EXAMINER
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Oct 28, 2025NWAPNEW APPLICATION ENTERED

Related guidance